SG3 Management’s Pulmonx LUNG Stock Holding History

SG3 Management’s Portfolio LUNG Stock Details LUNG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-166,500	Closed	-$4.13M	–	642
2022 Q1	$4.13M	Buy	166,500 +121,500	+270%	+$3.14M	0.12%	160
2021 Q4	$1.44M	Buy	+45,000	New	+$1.64M	0.03%	404

Other funds holding LUNG

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

SG3 Management's LUNG Position: Q2 2022 in Review

SG3 Management sold out of Pulmonx (LUNG) in Q2 2022, closing a stake of 166,500 shares — an estimated $4.13M sold.

SG3 Management first reported a position in LUNG in Q4 2021 and held it in 2 quarters. The position peaked at $4.13M in Q1 2022. 107 funds tracked by Wall St. Rank hold LUNG as of Q2 2022.

SG3 Management reported no remaining Pulmonx position as of Q2 2022 after selling out during the quarter.
SG3 Management sold 166,500 Pulmonx shares in Q2 2022, an estimated $4.13M.
SG3 Management first reported a position in Pulmonx in Q4 2021 and held it in 2 quarters.
SG3 Management's Pulmonx position peaked at $4.13M in Q1 2022.
107 funds tracked by Wall St. Rank held Pulmonx as of Q2 2022.

Based on SG3 Management's 13F filing for Q2 2022, filed 15 Aug 2022.